| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$202,708,978 |
|
|
|
Indirect Value
|
$172,941,055 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 21 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-21 |
4 |
B |
$16.65 |
$665,928 |
D/D |
40,000 |
3,311,465 |
2.39 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-06-10 |
4 |
B |
$1.97 |
$666,807 |
I/I |
339,083 |
2,071,883 |
1.5 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2019-03-14 |
4 |
B |
$1.21 |
$668,492 |
I/I |
552,427 |
3,822,908 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-03-30 |
4 |
B |
$8.59 |
$687,200 |
I/I |
80,000 |
14,181,928 |
2.25 |
% |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-06 |
4 |
OE |
$32.88 |
$706,387 |
D/D |
18,172 |
1,899,203 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2010-12-06 |
4 |
D |
$77.38 |
$706,479 |
D/D |
(9,130) |
1,893,365 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-21 |
4 |
B |
$9.01 |
$717,647 |
I/I |
79,650 |
14,440,935 |
2.25 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2017-07-03 |
4 |
B |
$4.00 |
$741,568 |
I/I |
185,392 |
1,383,421 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-02-18 |
4 |
S |
$2.95 |
$762,527 |
I/I |
(258,300) |
10,582,117 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-03-17 |
4 |
A |
$7.71 |
$771,360 |
I/I |
100,000 |
189,267 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2017-08-31 |
4 |
OE |
$1.00 |
$773,003 |
I/I |
773,003 |
3,905,223 |
0 |
- |
|
| BIOL |
Biolase Inc |
|
• • • |
2020-02-11 |
4 |
S |
$0.60 |
$784,759 |
I/I |
(1,307,931) |
739,820 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-09-27 |
4 |
B |
$5.33 |
$799,500 |
I/I |
150,000 |
17,002,654 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-23 |
4 |
B |
$9.90 |
$808,048 |
I/I |
81,621 |
14,680,244 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-09 |
4 |
B |
$10.63 |
$816,278 |
I/I |
76,790 |
12,032,376 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-03-27 |
4 |
B |
$8.09 |
$824,881 |
I/I |
101,963 |
14,101,928 |
2.25 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-19 |
4 |
S |
$1.91 |
$836,809 |
D/D |
(438,120) |
6,919,392 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-13 |
4 |
B |
$9.46 |
$842,460 |
I/I |
89,055 |
14,863,997 |
2.25 |
% |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4/A |
D |
$42.30 |
$853,699 |
D/D |
(20,182) |
2,312,168 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4 |
D |
$42.30 |
$853,699 |
D/D |
(20,182) |
1,224,193 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4 |
OE |
$6.31 |
$853,752 |
D/D |
129,000 |
1,244,375 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4/A |
OE |
$6.31 |
$853,752 |
D/D |
129,000 |
2,332,350 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-11-04 |
4 |
B |
$16.80 |
$862,462 |
I/I |
51,337 |
10,878,770 |
2.25 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2003-12-16 |
4 |
OE |
$12.63 |
$883,750 |
D/D |
70,000 |
1,091,664 |
|
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-10-18 |
4 |
B |
$20.14 |
$906,300 |
I/I |
45,000 |
13,040,117 |
2.25 |
- |
|
634 Records found
|
|
Page 21 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
